Pacira BioSciences, Inc. (PCRX)
Pharmaceutical Preparations
Latest Price
$24.08
TTM P/E
66.89
Normalized P/E
--
Div Yield
--
Book Value
16.82
P/B Ratio
1.43
Valuation metrics
adjust assumptions →EPS: $0.16
Book value / share: $16.86
Formula: √(22.5 × EPS × BVPS)
Graham Number
$7.79
68% downside
Norm. op. income: $46M (median of 7yr)
Tax rate: 32%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$4.41
82% downside
Base FCF: $137M (median of recent 5yr)
Growth: 23%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$211.51
+778% upside
EPS: $0.16
Target P/E: 67×
Formula: EPS × P/E
P/E Fair Value
$10.72
55% downside
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 6.71M | $170.0M | 16.84% | -29.5K | 2026-06-30 |
| Doma Perpetual Capital Management LLC | 2.78M | $70.0M | 6.98% | -- | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.41M | $61.0M | 6.04% | -95.0K | 2026-06-30 |
| DIMENSIONAL FUND ADVISORS LP | 2.10M | $53.0M | 5.28% | +42.6K | 2026-06-30 |
| STATE STREET CORP | 2.06M | $52.0M | 5.17% | +140.4K | 2026-06-30 |
| D. E. Shaw & Co., Inc. | 1.95M | $49.0M | 4.90% | -32.4K | 2026-06-30 |
| RENAISSANCE TECHNOLOGIES LLC | 1.73M | $43.0M | 4.35% | -91.7K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.69M | $42.0M | 4.25% | -92.5K | 2026-06-30 |
| GOLDMAN SACHS GROUP INC | 1.53M | $38.0M | 3.83% | -42.8K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.16M | $29.0M | 2.91% | +14.9K | 2026-06-30 |